PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1200
https://www.valueinhealthjournal.com/article/S1098-3015(11)02762-8/fulltext
Title : PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02762-8&doi=10.1016/j.jval.2011.08.1200
First page : A452
Section Title : Cancer
Open access? : No
Section Order : 1159
Categories :
Tags :
Regions :
ViH Article Tags :